HOPE Against Cancer Recurrence in HCC

Recruiting

Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.

Trial locations(37 sites)

United States

Rutgers New Jersey Medical School (New York), New York, New York

Cleveland Clinic, Cleveland, Ohio

Austria

Medical University of Innsbruck, Innsbruck

Medical University of Vienna, Vienna

Belgium

University Hospitals Leuven, Leuven